Sahajanand Medical Technologies posts record Q2 revenue!

Sahajanand Medical Technologies operates in the medical devices industry, where demand for specialised healthcare products and medical procedures can create opportunities for business expansion. Three developments stand out: 1. Record revenue: The company achieved its highest quarterly revenue, showing continued business expansion. 2. Operating leverage: EBITDA growth of 36.6% exceeded revenue growth of 24.7%. 3. International contribution: Europe remained an important market, contributing more than one-third of quarterly revenue. The faster EBITDA growth is particularly encouraging because it suggests improved operating performance alongside higher sales. My view The Q2 performance is positive across revenue, EBITDA and net profit. However, investors should examine whether the company can maintain this growth without a significant increase in operating expenses. International expansion, product demand and profitability will be important factors to monitor. What to watch next - Revenue growth in India and Europe. - EBITDA margin sustainability.